首页> 外文期刊>MDM Policy & Practice >Developing and Validating Metamodels of a Microsimulation Model of Infant HIV Testing and Screening Strategies Used in a Decision Support Tool for Health Policy Makers
【24h】

Developing and Validating Metamodels of a Microsimulation Model of Infant HIV Testing and Screening Strategies Used in a Decision Support Tool for Health Policy Makers

机译:开发和验证婴幼儿艾滋病检测微观模型的形态学和卫生政策制定者决策支持工具的筛选策略

获取原文
           

摘要

Background. Metamodels can simplify complex health policy models and yield instantaneous results to inform policy decisions. We investigated the predictive validity of linear regression metamodels used to support a real-time decision-making tool that compares infant HIV testing/screening strategies. Methods. We developed linear regression metamodels of the Cost-Effectiveness of Preventing AIDS Complications Pediatric (CEPAC-P) microsimulation model used to predict life expectancy and lifetime HIV-related costs/person of two infant HIV testing/screening programs in South Africa. Metamodel performance was assessed with cross-validation and Bland-Altman plots, showing between-method differences in predicted outcomes against their means. Predictive validity was determined by the percentage of simulations in which the metamodels accurately predicted the strategy with the greatest net health benefit (NHB) as projected by the CEPAC-P model. We introduced a zone of indifference and investigated the width needed to produce between-method agreement in 95% of the simulations. We also calculated NHB losses from “wrong” decisions by the metamodel. Results. In cross-validation, linear regression metamodels accurately approximated CEPAC-P-projected outcomes. For life expectancy, Bland-Altman plots showed good agreement between CEPAC-P and the metamodel (within 1.1 life-months difference). For costs, 95% of between-method differences were within $65/person. The metamodels predicted the same optimal strategy as the CEPAC-P model in 87.7% of simulations, increasing to 95% with a zone of indifference of 0.24 life-months ( ~ 7 days). The losses in health benefits due to “wrong” choices by the metamodel were modest (range: 0.0002–1.1 life-months). Conclusions. For this policy question, linear regression metamodels offered sufficient predictive validity for the optimal testing strategy as compared with the CEPAC-P model. Metamodels can simulate different scenarios in real time, based on sets of input parameters that can be depicted in a widely accessible decision-support tool.
机译:背景。元模型可以简化复杂的健康政策模型,并产生瞬间结果以告知政策决策。我们调查了用于支持对比较婴儿艾滋病毒检测/筛选策略的实时决策工具的线性回归元典的预测有效性。方法。我们开发了预防艾滋病并发症的成本效益的线性回归形态,用于预测南非两种婴儿艾滋病毒检测/筛选计划的寿命和终身艾滋病毒相关成本/人的寿命和终身艾滋病病程。用交叉验证和平坦-Attman地块评估元模型性能,显示出对其手段预测结果的方法差异。预测有效性由模拟的百分比确定,其中元模型准确地预测了由CEPAC-P模型预计的最大净健康益处(NHB)的策略。我们介绍了一个漠不关心的区域,并调查了在95%的模拟中产生了方法协议所需的宽度。我们还通过Metomodel计算了“错误”决策的NHB损失。结果。在交叉验证中,线性回归元模型精确地近似CEPAC-P-Pregined结果。对于预期寿命,Bland-Altman情节在Cepac-P和Metomodel之间表现出良好的一致性(在1.1寿命期内)。为了成本,95%的方法之间的差异在65美元内。 Metomodels预测了与仿真的87.7%的CEPAC-P型号相同的最佳策略,增加到95%,带有0.24寿命的幼稚区(〜7天)。 Metamodel选择的健康效益损失是适度的(范围:0.0002-1.1寿命)。结论。对于此策略问题,与CEPAC-P型号相比,线性回归元模型为最佳测试策略提供了足够的预测有效性。 Metomodels可以实时模拟不同的场景,基于可在广泛访问的决策支持工具中描绘的输入参数。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号